- Home
- ACEL vs KURA Comparison
ACEL vs KURA Comparison
Compare ACEL & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACEL | KURA |
|---|---|---|
| Founded | 2009 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 841.6M |
| IPO Year | 2017 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ACEL | KURA |
|---|---|---|
| Price | $12.01 | $9.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 11 |
| Target Price | $14.67 | ★ $25.56 |
| AVG Volume (30 Days) | 241.1K | ★ 1.4M |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 46.34 | N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | N/A | ★ $67,482,000.00 |
| Revenue This Year | $7.07 | $28.28 |
| Revenue Next Year | $2.81 | $106.37 |
| P/E Ratio | $70.71 | ★ N/A |
| Revenue Growth | N/A | ★ 25.24 |
| 52 Week Low | $9.55 | $5.45 |
| 52 Week High | $14.00 | $12.49 |
Technical Indicators
Market Signals| Indicator | ACEL | KURA |
|---|---|---|
| Relative Strength Index (RSI) | 39.58 | 33.93 |
| Support Level | $11.71 | $8.53 |
| Resistance Level | $13.29 | $9.82 |
| Average True Range (ATR) | 0.31 | 0.52 |
| MACD | -0.03 | -0.28 |
| Stochastic Oscillator | 11.81 | 5.97 |
Price Performance
Historical ComparisonAbout ACEL Accel Entertainment Inc.
Accel Entertainment Inc is a distributed gaming and local entertainment operator in the United States. It is engaged in the installation, maintenance, operation, and servicing of gaming terminals and related equipment, redemption devices that disburse winnings and contain automated teller machine (ATM) functionality, and amusement devices in authorized non-casino locations such as restaurants, bars, convenience stores, liquor stores, truck stops, and grocery stores. The Company also operates stand-alone ATMs in gaming and non-gaming locations. It generates revenue from Net gaming, Amusement, Manufacturing, ATM fees, and others.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.